NLRP6 and colorectal carcinoma: Beyond that, there are a lot of plant extracts that target other NLRs inflammasomes, such as apigenin, a flavonoid, that protects against colitis in mice by inhibiting the NLRP6 signaling pathway, which is currently in clinical trials for CRC and breast cancer (117) (Table 2).